DIGITAL TRANSFORMATION’S IMPACT ON THE PHARMACEUTICAL LIFECYCLE
Traditionally, the pharmaceutical industry has been relatively slow to adopt and commit to digital transformation initiatives. However, in-part due to the disruption caused by the COVID-19 pandemic, these organizations have begun to make investments into digital technologies designed to streamline processes, enhance innovation, and maximize efficiencies. Now, we’re seeing digital innovation become a top priority for pharma leaders, with more than 70% of biopharma organizations reporting that they are re-platforming scientific data to the cloud to enable scale, resilience, and faster time-to-market. In this article, we’ll examine how digital transformation is impacting pharma throughout its lifecycle—from research and development through clinical trials, supply chain management, and commercialization—and provide actionable next steps for starting the transformation journey.